Stem cell specialists StemCultures and growth factor manufacturer Qkine will develop new controlled-release growth factors that allow fine control of stem cell expansion and differentiation
Our Co-Founder and President, Dr. Sally Temple, has been elected to the National Academy of Medicine Class of 2022. Dr. Temple joins the 2,200 others
StemCultures Celebrates 10 Years of Controlled Growth Factor Delivery and Innovative Discovery Scientific discovery answers life’s challenging questions. A problem is identified, and a solution
China was a tempting location for StemCultures to offshore its manufacturing to, but this Rensselaer company abandoned its exploration to do so despite already offshoring
Sustained release growth factory delivery with FGF2 DISCs for reproducible 3D cultures Conventional human pluripotent stem cell (PSC) culture for organoid production requires a rigorous
NIH Award for StemCultures In fiscal 2021, 16 local firms and institutions received $73.6 million from 152 NIH awards. That included more than $3.2 million
The Nobel Prize–winning discovery that mature, specialized cells can be reprogrammed to lend them pluripotency (that is, the ability to develop into all tissues of
StemCultures® team members Sally Temple, Ph.D., and Jeffrey Stern, Ph.D., M.D., are continuing to make waves in the stem cell community. They recently received FDA
